Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Infertility 1Helping Behavior 1

Interventions

Clomiphene 22Metformin 14Letrozole 12Triptorelin Pamoate 7cetrorelix 6Menotropins 6Inositol 6follitropin alfa 4Therapeutics 4Folic Acid 4Chorionic Gonadotropin 4Uterine Myomectomy 3Surveys and Questionnaires 3Sperm Injections, Intracytoplasmic 3Psychiatric Rehabilitation 3Medroxyprogesterone Acetate 3Gonadotropins 3ulipristal acetate 2follitropin beta 2Tamoxifen 2Sugars 2Progestins 2Liraglutide 2Lactalbumin 2High-Energy Shock Waves 2Goserelin 2Flutamide 2Fertilization in Vitro 2Dydrogesterone 2Cyclophosphamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infertility × Urofollitropin × Clear all
NCT01185782 2013-12-27

SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
300 enrolled 18 charts

Helping Behavior, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡